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ABSTRACT
Introduction: Asthma is a common long-term
disorder with a number of related comorbid conditions,
which may affect asthma outcomes. There is a need
for greater appreciation for understanding how these
comorbidities interact with asthma in order to improve
asthma outcomes.
Objectives: To systematically identify and map out
key asthma comorbidities.
Methods: We will systematically search the following
electronic databases: MEDLINE, EMBASE, ISI Web of
Science, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), PsycINFO and Google Scholar.
Additional literature will be identified by searching the
reference list of identified eligible studies and by
searching the repositories of international conference
proceedings, including ISI Conference Proceeding
Citation Index, and ZETOC (British Library).
Dissemination: The findings from this systematic
scoping review will be reported at scientific meetings
and published in a peer-reviewed journal.
BACKGROUND
Asthma is typically a lifelong disease and
affects over 300 million people worldwide.1 It
is responsible for considerable morbidity,
mortality and substantial healthcare costs.1 2
Effective self-management and pharmaco-
therapy leading to well-controlled asthma is
the key management goal.3–5 Key indicators
of successful asthma control include minimal
or no symptoms, no restrictions on activities,
optimal pulmonary function and minimal or
no side-effects of treatment.3–6 Poor asthma
control is believed mainly to result from inad-
equate/suboptimal treatment and problems
with adherence to recommended treatments.4 5
An important consideration as well is the
impact of comorbid diseases on asthma.4 5 7–10
Many deﬁnitions exist for asthma as there is a
signiﬁcant proportion of heterogeneity; the
deﬁnition adopted here is a doctor-diagnosed
or patient-reported asthma ever.
The presence of more than one condition
in a person is the widely suggested concept
for comorbidity.11 The doctor-diagnosed dis-
eases should be linked to the International
Classiﬁcation of Diseases (ICD) regardless of
their chronological occurrence (before or
after the index condition: asthma). The
importance of comorbidities lies not only in
their presence but also in their severity that
can be used to convey the concept of
‘burden of disease’.11 The Charlson Index is
commonly used to compare and understand
the complexity of coexisting diseases. A
number of conditions (eg, allergic rhinitis,
gastro-oesophageal reﬂux disease (GORD),
obesity and depression) may occur more fre-
quently in people with asthma than in those
without asthma, leading to potential additional
difﬁculties in asthma management.12 13 These
comorbid conditions may be associated with
poor asthma control, impaired health-related
quality of life (HRQoL) and increased health
and social care usage.12–19 The systematic iden-
tiﬁcation and mapping of these comorbid con-
ditions may lead to customised, targeted
treatment, which in turn offers the potential
to substantially improve outcomes in patients
with asthma, and thereby reduce the need for
health and social care.4 12 19 20
There are a number of international
studies investigating asthma comorbidity,
impact on asthma control and HRQoL, and
consequent healthcare and societal burden,
but their results vary depending on the
populations studied and the particular
comorbid conditions that are the focus of
these investigations.21–23 There is a need
Strengths and limitations of this study
▪ To the best of our knowledge, this is the first
review undertaken to map out the full spectrum
of asthma comorbidity; hence, evidence gener-
ated from the review will be important in shaping
the direction of the field.
▪ The scoping review will be limited to the past
5 years only, but aimed to map the most con-
temporaneous evidence on asthma comorbidity.
▪ As a scoping review, formal quality assessment
and risk of bias will not be undertaken on
studies to be included in the review.
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therefore for a systematic investigation into the range of
asthma comorbidities. This scoping review aims to ﬁll
this need and, in addition, identify important research
gaps in understanding the relationship between asthma
and its comorbidities. It will not focus on studies that
have looked at the association between asthma and
other diseases and vice versa but on studies that have
investigated the impact of other conditions on asthma
outcomes.
METHODS
Eligibility criteria
Types of studies
Cohort studies, case–control studies and cross-sectional
studies will be eligible for inclusion. We will exclude edi-
torials, animal studies, reviews, randomised controlled
trials (RCTs), quasi-RCTs, case studies and case series.
Participants
We are interested in studies on participants of any age
with a clinical diagnosis of asthma.
Outcome
Clinical diagnosis of asthma: doctor-diagnosed asthma
ever or current assessed subjectively (patient reported)
or objectively (health/medical records).
Asthma and the comorbidities of interest
As this is only a scoping review, our aim is to uncover the
various approaches that have been employed, including
the deﬁnition of asthma that authors have employed.
Therefore, restricting ourselves to a speciﬁc deﬁnition of
asthma may also be restrictive to our objective of the
scoping systematic review.
The comorbidities that we are interested in are those
that exacerbate asthma’s management and prognosis
(eg, effect of asthma), regardless of whether they
develop before or after asthma. We will also group
comorbidities according to the Charlson Comorbidity
Index, a method of categorising comorbidities of
patients based on the ICD diagnosis codes. We are inter-
ested in studies on asthma comorbidities; these are likely
to include, but are not limited to, allergic diseases, car-
diovascular diseases, chronic obstructive pulmonary
disease, autoimmune disorders (eg, type 1 diabetes),
metabolic disorders (eg, type 2 diabetes, obesity),
eosinophilic diseases, psychological dysfunction (anxiety,
depression), hypertension, cardiovascular diseases and
GORD.
Search methods
Databases
We will identify published studies from the following
databases: MEDLINE, EMBASE, ISI Web of Science,
Cumulative Index to Nursing and Allied Health
Literature (CINAHL), PsycINFO and Google Scholar.
Additional literature will be identiﬁed by searching the
reference list of identiﬁed eligible studies and by search-
ing the repositories of international conference proceed-
ings, including ISI Conference Proceeding Citation
Index, and ZETOC (British Library). Unpublished litera-
ture and ongoing studies will be identiﬁed by searching
the following registries: ISI Conference Proceedings
Citation Index via Web of Knowledge.
Search strategy
A highly sensitive search strategy has been developed in
each of the six databases to capture the broad literature
on the topic (see online supplementary appendix).
Using bibliographic databases and health-oriented
search engines, the search will encompass the main
concept of our scoping review: asthma comorbidities.
In order to maximise the sensitivity of our search, we
are not only restricting our overall strategy to topic
searches in literature databases but are also taking these
steps: consulting with experts in the ﬁeld, looking in
clinical trials registers, looking in conference proceed-
ings, looking in grey literature such as PhD theses, doing
forward and backward citation tracking, interrogating
the websites of key organisations and hand-searching
journals. We will search from March 2014 until March
2016. Although it is well known that researchers have
been studying asthma as a heterogeneous disease
affected by multiple comorbidities, however, the evi-
dence on asthma and comorbidities increased exponen-
tially in the past years. In addition, our preliminary
search provided over 20 000 records from one database;
this 2-year time frame will enable us to achieve our
objectives in a pragmatic manner.
Study selection
The articles retrieved from the search strategy will be
screened according to the review inclusion and exclu-
sion criteria. The titles and abstracts will be independ-
ently screened by two investigators for potentially
eligible studies, and when there is a difference in opi-
nions, discussions will be undertaken to reach a consen-
sus on each article. If an agreement is not reached, a
third reviewer will arbitrate. The full text versions of
potentially relevant studies will be retrieved and
screened independently by two reviewers; consensus will
be carried out through discussions and a third reviewer
will arbitrate if no agreement reached on any study. All
the studies not meeting the inclusion criteria will be
excluded. Study screening will be undertaken and
reported according to the Preferred Reporting Items for
Systematics Reviews and Meta-analyses’ (PRISMA)
recommendation.24
Data extraction
A customised data extraction form will be constructed to
extract all relevant data from each study. The data
extraction form will be piloted on a few of the eligible
studies to evaluate its reliability in capturing the study
data of interest. Data extraction will be undertaken
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independently by two reviewers. Any disagreements will
be resolved by discussion or arbitration by a third
reviewer. Descriptive summary tables will be produced to
recapitulate the evidence base. The following data will
be extracted:
▸ Author(s) and date;
▸ Geographical location;
▸ Research design;
▸ Aims;
▸ Research questions;
▸ Methods;
▸ Settings;
▸ Participants (N, mean age, gender if available);
▸ Comorbidities studied;
▸ Key ﬁndings;
▸ Research gaps identiﬁed.
An initial map will be developed to explore the main
comorbidities associated with asthma. Then the ﬁndings
will be synthesised in a descriptive and a narrative review
and summarised in a concise table to facilitate the com-
parisons of different comorbidities. The replication of
results and discrepancies will be investigated. The results
will be then stratiﬁed according to different age groups,
gender and other relevant indicators of interest. The
scoping review designed will be developed according to
the Levac et al’s25 framework and the reporting will
follow the PRISMA checklist.24
CONCLUSIONS
This systematic scoping review will provide a comprehen-
sive overview of asthma comorbidities. We expect to
report in the summer of 2016.
ETHICS AND DISSEMINATION
As there are no primary data collected, there will be
need for formal National Health Service ethical review.
The systematic scoping review will be presented at a rele-
vant conference and be published in a peer-reviewed
journal.
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